HIGHLIGHTS
- who: Mary M. Kavurma from the University of Miami, United States have published the paper: Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease, in the Journal: (JOURNAL)
- what: Below, the authors focus the attention on some of these therapies as well as describe emerging therapies known to impact EC functions.
- how: More recently the authors showed that administration of CL316243 a specific u03b2 3 AR agonist stimulated human umbilical vein EC migration and tubule formation in a NOS-dependent manner in_vitro and crucially CL316243 improved blood perfusion and angiogenesis in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.